News

Mabswitch wins GoldenTicket supported by Abbvie

At a Pitch Day competition in Los Angeles hosted by GeneOnline US in collaboration with the Taiwan Biomedical Innovation Association (TiBIA), aimed at discovering transformative start-ups that could revolutionize the field, Mabswitch Inc. was awarded the “Best Breakthrough Award“. The Read more…

Barcelona, March 19, 2024 – Mabswitch was selected out of several biotech start-up companies to be part of the 8 finalists pitching at the StartUP Spotlight taking place during BIO Europe Spring 2024 in Barcelona,  and emerged as the winner Read more…

Los Angeles, CA – Mabswitch Inc, a pioneering biotechnology company at the forefront of cutting-edge bioprocess technologies, is proud to announce that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 grant by the National Center for Read more…

Los Angeles, CA – Mabswitch Inc, a pioneering biotechnology company at the forefront of cutting-edge cancer immunotherapies, is proud to announce that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 grant by the National Cancer Institute Read more…

Mabswitch was awarded the Bristol Myers Squibb Golden Ticket. The award provides one year of fully paid individual laboratory bench space and membership at BioLabs@NYULangone, a fully equipped, laboratory-based incubator in Manhattan with facilities, support and equipment designed to accelerate Read more…

The MBC BioLabs Diversity Golden Ticket supported by AbbVie award provides lab space fitted with state-of-the-art research equipment, professional support staff, conference room space for meetings, and a vibrant, collaborative community to share ideas and expertise with other exciting life Read more…